Montelukast improves symptoms of seasonal allergic rhinitis over a 4-week treatment period.

van Adelsberg, J; Philip, G; Pedinoff, A J; Meltzer, E O; Ratner, P H; Menten, J; Reiss, T F

van Adelsberg, J; Philip, G; Pedinoff, A J; Meltzer, E O; Ratner, P H; Menten, J; Reiss, T F.

Affiliation

van Adelsberg J; Merck Research Laboratories, Rahway, NJ, USA.

Allergy ; 58(12): 1268-76, 2003 Dec.

Article in En | MEDLINE | ID: mdl-14616102

Subject(s)

Acetates/therapeutic use; Leukotriene Antagonists/therapeutic use; Quinolines/therapeutic use; Rhinitis, Allergic, Seasonal/drug therapy; Adolescent; Adult; Aged; Anti-Allergic Agents/therapeutic use; Cyclopropanes; Double-Blind Method; Female; Humans; Loratadine/therapeutic use; Male; Middle Aged; Sulfides; Treatment Outcome

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Quinolines / Rhinitis, Allergic, Seasonal / Leukotriene Antagonists / Acetates Type of study: Clinical_trials / Diagnostic_studies Aspects: Patient_preference Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Allergy Year: 2003 Document type: Article Affiliation country: United States Country of publication: Denmark

Search on Google

Add to My VHL

XML

PubMed Links